Proposed LCD - MolDX: Molecular Testing for Solid Organ Allograft Rejection (DL38582)

Covered tests with AV that is significantly below similar services may have coverage rescinded.General InformationAssociated InformationN/ASources of InformationN/ABibliographyUSRDS Coordinating Center United States Renal Data System. 2018;USRDS. Accessed 6/2/2023.Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.Eur J Heart Fail. 2016;18(8):891-975.Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.J Am Coll Cardiol. 2013;62(16):e147-239.United States Government Accountability Office. End-Stage Renal Disease: Characteristics of Kidney Transplant Recipients, Frequency of Transplant Failures, and Cost to Medicare. In:2007.Seron D, Arns W, Chapman JR. Chronic allograft nephropathyclinical guidance for early detection and early intervention strategies.Nephrol Dial Transplant. 2008;23(8):2467-2473.Lamb KE, Lodhi S, Meier-Kriesche HU. Long-term renal allograft survival in the United States: a critical reappraisal.Am J Transplant. 2011;11(3):450-462.Stegall MD, Gaston RS, Cosio FG, Matas A. Through a glass darkly: seeking clarity in preventing late kidney transplant failure.J Am Soc Nephrol. 2015;26(1):20-29.Stehlik J, Kobashigawa J, Hunt SA, Reichenspurner H, Kirklin JK. Honoring 50 years of clinical heart transplantation inCirculation: in-depth state-of-the-art review.Circulation. 2018;137(1):71-87.McManigle W, Pavlisko EN, Martinu T. Acute cellular and antibody-mediated allograft rejection.Semin Respir Crit Care Med. 2013;34(3):320-335.Haas M, Loupy A, Lefaucheur C, et al. The Banff 2017 kidney meeting report: revised diagnostic criteria for chronic active T cellmediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials.Am J Transplant. 2018;18(2):293-307.Solez K, Axelsen RA, Benediktsson H, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology.Kidney Int. 1993;44(2):411-422.Bruneval P, Angelini A, Miller D, et al. The XIIIth Banff conference on allograft pathology: The Banff 2015 heart meeting report: improving antibody-mediated rejection diagnostics: strengths, unmet needs, and future directions.Am J Transplant. 2017;17(1):42-53.Stewart S, Winters GL, Fishbein MC, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection.J Heart Lung Transplant. 2005;24(11):1710-1720.Mehr MR. Heart transplantation at 50.Lancet. 2017;390(10111):E43-E45.Nankivell BJ, Alexander SI. Rejection of the kidney allograft.N Engl J Med. 2010;363(15):1451-1462.Richmond ME, Zangwill SD, Kindel SJ, et al. Donor fraction cell-free DNA and rejection in adult and pediatric heart transplantation.J Heart Lung Transplant. 2020;39(5):454-463.Levitsky J, Asrani SK, Schiano T, et al. Discovery and validation of a novel blood-based molecular biomarker of rejection following liver transplantation.Am J Transplant. 2020;20(8):2173-2183.Sigdel TK, Archila FA, Constantin T, et al. Optimizing detection of kidney transplant injury by assessment of donor-derived cell-free DNA via massively multiplex PCR.J Clin Med. 2018;8(1).Bloom RD, Bromberg JS, Poggio ED, et al. Cell-free DNA and active rejection in kidney allografts.J Am Soc Nephrol. 2017;28(7):2221-2232.Bromberg JS, Brennan DC, Poggio E, et al. Biological variation of donor-derived cell-free DNA in renal transplant recipients: clinical implications.J App Lab Med. 2017;2(3):309-321.Grskovic M, Hiller DJ, Eubank LA, et al. Validation of a clinical-grade assay to measure donor-derived cell-free DNA in solid organ transplant recipients.J Mol Diagn. 2016;18(6):890-902.First MR, Whisenant T, Friedewald JJ, et al. Clinical utility of peripheral blood gene expression profiling of kidney transplant recipients to assess the need for surveillance biopsies in subjects with stable renal function.J Transplant Technol Res. 2017;7(3).Marsh C, Kurian SM, Rice J, et al. Application of TruGraf v1: a novel molecular biomarker for managing kidney transplant recipients with stable renal function.Transplant Proc. 2019;51(3):722-728.Roedder S, Sigdel T, Salomonis N, et al. The kSORT assay to detect renal transplant patients at high risk for acute rejection: results of the multicenter AART study.PLoS Med. 2014;11(11).Beck J, Oellerich M, Schulz U, et al. Donor-derived cell-free DNA is a novel universal biomarker for allograft rejection in solid organ transplantation.Transplant Proc. 2015;47(8):2400-2403.Kurian S, Velazquez E, Thompson R, et al. Orthogonal comparison of molecular signatures of kidney transplants with subclinical and clinical acute rejection: equivalent performance is agnostic to both technology and platform.Am J Transplant. 2017;17(8):2103-2116.Pham MX, Teuteberg JJ, Kfoury AG, et al. Gene-expression profiling for rejection surveillance after cardiac transplantation.N Engl J Med. 2010;362(20):1890-1900.Khush KK, Patel J, Pinney S, et al. Noninvasive detection of graft injury after heart transplant using donor-derived cell-free DNA: a prospective multicenter study.Am J Transplant. 2019;19(10):2889-2899.Pattar SKG, Steven C. Circulating nucleic acids as biomarkers for allograft injury after solid organ transplantation: current state-of-the-art.Transplant Research and Risk Management. 2019;11:17-27.Schutz E, Fischer A, Beck J, et al. Graft-derived cell-free DNA, a noninvasive early rejection and graft damage marker in liver transplantation: a prospective, observational, multicenter cohort study.PLoS Med. 2017;14(4):e1002286.Guzzi F, Cirillo L, Buti E, et al. Urinary biomarkers for diagnosis and prediction of acute kidney allograft rejection: a systematic review.Int J Mol Sci.2020;21(18).Adam B, Afzali B, Dominy KM, et al. Multiplexed color-coded probe-based gene expression assessment for clinical molecular diagnostics in formalin-fixed paraffin-embedded human renal allograft tissue.Clin Transplant. 2016;30(3):295-305.Sigdel T, Nguyen M, Liberto J, et al. Assessment of 19 genes and validation of CRM gene panel for quantitative transcriptional analysis of molecular rejection and inflammation in archival kidney transplant biopsies.Front Med (Lausanne). 2019;6:213.Depasquale E, Hall S, Crespo-Leiro M, Kao A, Teuteberg J, Hiller D, Yee J. Combination of cell-free DNA with gene-expression profiling in the diagnosis of acute rejection.J Heart Lung Transplant. 2019;38:S387.Fryback DG, Thornbury JR. The efficacy of diagnostic imaging.Med Decis Making. 1991;11(2):88-94.